Palliative treatment of germ cell cancer.

Oing C; Giannatempo P; Honecker F; Oechsle K; Bokemeyer C; Beyer J

doi:10.1016/j.ctrv.2018.10.007

Back

Journal article

Palliative treatment of germ cell cancer.

Oing C Department of Oncology, Hematology and Bone Marrow Transplantation with Department of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Giannatempo P Department of Medical Oncology, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy.
Honecker F ZeTuP Breast and Tumor Center, St. Gallen, Switzerland.
Oechsle K Department of Oncology, Hematology and Bone Marrow Transplantation with Department of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Bokemeyer C Department of Oncology, Hematology and Bone Marrow Transplantation with Department of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Beyer J Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse, CH-3031 Bern, Switzerland. Electronic address: joerg.beyer@insel.ch.

2018-11-12

Published in:

Cancer treatment reviews. - 2018

Antineoplastic Combined Chemotherapy Protocols

Neoplasms, Germ Cell and Embryonal

Peripheral Nervous System Diseases

English Most patients with metastatic germ-cell cancer (GCC) can be cured by cisplatin-based combination chemotherapy. Yet, about 10-15% of metastatic GCC patients will eventually die of their disease. This narrative review focuses on treatment options when cure is no longer realistic.

Language